Results 211 to 220 of about 211,280 (349)

Rescue Tirofiban for Early Neurological Deterioration After Tenecteplase in Capsular Warning Syndrome. [PDF]

J Clin Neurol
Cuccurullo C, De Mase A, Candelaresi P, Andreone V.   +3 more
europepmc   +1 more source

Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial.

The Lancet, 2016
M. I. Baharoglu, C. Cordonnier, R. Salman, K. de Gans, M. Koopman, A. Brand, C. Majoie, L. Beenen, H. Marquering, M. Vermeulen, P. Nederkoorn, R. D. de Haan, Y. Roos   +12 more
semanticscholar   +1 more source

The burden of diabetic foot ulcers in a multi‐ethnic Asian cohort

Diabetic Medicine, EarlyView.
Abstract Aims Diabetic foot ulcers (DFUs) are a major source of morbidity among individuals with diabetes mellitus (DM), imposing a substantial burden on healthcare systems. Our institution established a multidisciplinary service aiming to facilitate early specialist intervention for DFU management.
Zongwen Wee, Yong Mong Bee, Sueziani Binte Zainudin   +2 more
wiley   +1 more source

P2Y₁₂ inhibitor pre-treatment in NSTE-ACS: translating trial evidence into UK clinical practice. [PDF]

Open Heart
Hesse K, Stephens J, Batty JA, Bayliss CD, Memon S, Loh SX, Telyuk P, Swanson N, Muir D, Jackson M, Carter J, Sutton A, Vijayan S, Williams PD, Akowuah E, Wilkinson C, Austin D.   +16 more
europepmc   +1 more source

Ocular Manifestations of Metabolic Syndrome: A Systemic Vascular Phenotype

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Context Metabolic syndrome (MetS) is defined by central obesity, insulin resistance, hypertension and dyslipidemia. MetS affects over one‐third of US adults. Beyond its cardiovascular burden, MetS has clinically relevant associations with ocular health and may contribute to a systemic vascular and neuro‐metabolic phenotype involving the retina,
Ron T. Varghese, Ansu A. John
wiley   +1 more source

A Therapeutic Dilemma: Catastrophic ST-Elevation Myocardial Infarction Following Antiplatelet Therapy Interruption in a Patient With JAK2-Positive Polycythemia Vera. [PDF]

Clin Case Rep
Zarei B, Rezaei Latifi A, Salari M.
europepmc   +1 more source

Antiplatelet Agents: A Review [PDF]

Journal of the Royal Society of Medicine, 1979
openaire   +2 more sources

Bowel Obstruction/Ileus Associated With the Use of Glucagon‐Like Peptide‐1 Receptor Agonists: A Nationwide Database Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The association between glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) use and the development of bowel obstruction/ileus remains unclear, and evidence for specific bowel obstruction/ileus subtypes remains limited. We examined the association between GLP‐1RA use and the incidence of bowel obstruction/ileus subtypes across different ...
Yuichiro Matsuo, Akira Okada, Takashi Sakamoto, Hideo Yasunaga   +3 more
wiley   +1 more source

Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials. [PDF]

PLoS One
Hlupeni A, Jalilzadehbinazar M, Liceralde RJ, Khan HAM, Donepudi R, Arora S.   +5 more
europepmc   +1 more source

Hospitalisation Is a Strong Risk Factor for Discontinuation of Sodium‐Glucose Cotransporter 2 Inhibitors for Type 2 Diabetes

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Sodium–glucose cotransporter 2 inhibitors (SGLT2i) are commonly withheld during hospitalisation because of concerns about diabetic ketoacidosis. We examined whether hospitalisation was associated with discontinuation of SGLT2i and compared patterns with another anti‐hyperglycaemic medicine without similar inpatient safety concerns ...
Tamara Y. Milder, Leah Shepherd, Hans Kristian Raket, Jerry R. Greenfield, Richard O. Day, Jialing Lin, Juliana de Oliveira Costa, Sophie Stocker, Carol A. Pollock, Brendon Neuen, Min Jun, Jane Ludington, Sallie‐Anne Pearson, Michael O. Falster   +13 more
wiley   +1 more source